Konstantin Poukalov

Konstantin Poukalov is the founder of ARYA Sciences Acquisition Corp.
III, founded in 2020, where the title held was Chief Business Officer from 2020 to 2021.
Mr. Poukalov is the founder of LianBio, founded in 2019, holding the title of Executive Chairman since 2019.
Mr. Poukalov is the founder of ARYA Sciences Acquisition Corp.
IV, founded in 2021, holding the title of Chief Business Officer since 2021.
Mr. Poukalov is the founder of ARYA Sciences Acquisition Corp.
V, founded in 2021, holding the title of Chief Business Officer since 2021.
Current jobs include Managing Director & Perceptive Discovery Co-Head at Perceptive Advisors (Private Equity) since 2019, Executive Director at Shanghai Lianbio Development Co., Ltd., Director at Prolaio, Inc., and Director at Vapotherm, Inc. since 2024.
Former jobs include Independent Director at Landos Biopharma, Inc. from 2019 to 2021, Independent Director at Lyra Therapeutics, Inc. from 2020 to 2024, Chief Financial & Accounting Officer, Executive VP at Kadmon Holdings, Inc. from 2014 to 2018, Member at Jefferies LLC from 2009 to 2012, Member at UBS Investment Bank (US) from 2006 to 2009, Chief Financial Officer & Executive Vice President at Kadmon Corp.
LLC, and Chief Business Officer at ARYA Sciences Acquisition Corp.
II.
Education includes undergraduate studies at Stony Brook University.